Baxter (BAX) Tops Q2 EPS by 5c

Go back to Baxter (BAX) Tops Q2 EPS by 5c

Leerink Partners Downgrades Baxter International (BAX) to Market Perform

July 30, 2015 7:43 AM UTC

Leerink Partners downgraded Baxter International (NYSE: BAX) from Outperform to Market Perform with a price target of $40.00 (from $82.00).

Analyst Danielle Antalffy commented, "We are downgrading BAX shares to MP with a $40 12-month price target. Despite delivering solid 2Q15 results, post-split new BAX valuation appears lofty to us, already seeming to factor in potential upside in both sales... More

Baxter (BAX) Declares $0.115 Quarterly Dividend; 1.2% Yield

July 29, 2015 4:18 PM UTC

Baxter (NYSE: BAX) declared a quarterly dividend at a new rate of $0.115 per share, or $0.46 annualized, following its successful spin-off of its biopharmaceuticals business, Baxalta Incorporated.

The dividend will be payable on October 1, 2015, to stockholders of record on September 4, 2015, with an ex-dividend... More